Search

Your search keyword '"Van Hemelrijck, Mieke"' showing total 72 results

Search Constraints

Start Over You searched for: Author "Van Hemelrijck, Mieke" Remove constraint Author: "Van Hemelrijck, Mieke" Publisher wiley Remove constraint Publisher: wiley
72 results on '"Van Hemelrijck, Mieke"'

Search Results

1. AllergoOncology: Biomarkers and refined classification for research in the allergy and glioma nexus—A joint EAACI‐EANO position paper

3. Risk of COVID‐19 death for people with a pre‐existing cancer diagnosis prior to COVID‐19‐vaccination: A systematic review and meta‐analysis

4. A protocol for the development of core outcome sets for effectiveness trials and clinical audits in renal cell cancer (R‐COS)

7. The experience of UK patients with bladder cancer during the second wave of the COVID‐19 pandemic

9. Impact of the COVID‐19 pandemic on urological cancers: The surgical experience of two cancer hubs in London and Milan

10. Supportive care needs and utilization of bladder cancer patients undergoing radical cystectomy: A longitudinal study

12. Risk of cardiovascular disease following gonadotropin‐releasing hormone agonists vs antagonists in prostate cancer: Real‐world evidence from five databases

14. The experience of UK patients with bladder cancer during the COVID‐19 pandemic: a survey‐based snapshot

15. Negative first follow‐up prostate biopsy on active surveillance is associated with decreased risk of upgrading, suspicion of progression and converting to active treatment

22. Survival after radiotherapy versus radical cystectomy for primary muscle-invasive bladder cancer : A Swedish nationwide population-based cohort study

24. Survival after radiotherapy versus radical cystectomy for primary muscle‐invasive bladder cancer: A Swedish nationwide population‐based cohort study

25. Real‐world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer: a methodological protocol to a study using five European databases

28. Association between type 2 diabetes, curative treatment and survival in men with intermediate- and high-risk localized prostate cancer

47. Is there an antiandrogen withdrawal syndrome with enzalutamide?

Catalog

Books, media, physical & digital resources